Hosted on MSN14h
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline
Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...
Moderna swings to Q4 loss after nearly 66% drop in revenue
Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...
Earnings call transcript: Moderna Q4 2024 sees revenue drop, market reacts
Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and ...
Indiatimes8h
Kotak Mahindra Bank Q4 results
Kotak Mahindra Bank’s share prices surged by over 5% on Monday, a day after the leading private sector lender announced its Q4 results. The company reported an 18.22% year-on-year increase in its ...